Gene fusion was the first mechanism identified for the oncogenic activation of the receptor tyrosine kinase RET (REarranged during Transfection), initially discovered in papillary thyroid carcinoma (PTC). This evidence concerns the gene NTRK1 and thyroid gland papillary carcinoma.